Monday, 4 April 2022

My Portfolio Mac22

 



Summary For March 2022











Portfolio @ End of Mac22














After a challenging month of Feb22, Mac22 was a volatile month for tech-related stocks in Bursa in which they fell heavily in the first week but then staged a V-shape recovery.

I just added a bit of Krono and JHM during this period of time. I still haven't averaged down on MI as its share price has already rebounded strongly before I made my move.

I planned to add MI's shares at RM1.50 but it didn't reach this level even though it was close.

In Mac, my portfolio suffered a 2.5% loss. Year-to-date the loss has widened to 3%.

Oil & gas stocks especially upstream Hibiscus have the exact opposite fate as the tech stocks.

The share price of Hibiscus rallied since the end of Jan22 from RM0.88 to reach RM1.38 on 9th Mac22, before falling 26% to almost RM1 in the next 4 days.

I sold my second batch of Hibiscus shares at RM1.28. I keep the rest to see how the market will respond to its upcoming quarter result which includes approximately 2 months contribution from acquired Repsol assets.


Sunday, 6 March 2022

Tech Stocks: Has The Value Emerged?



Can I buy tech stocks now?

I think most stock market investors in Malaysia will have this question.

Year-to-date, most tech-related stocks have seen their share price dropped between 30-50%. Their previous optimistic PE valuation of 40-60x has fallen to 20-30x currently.

PE ratio of between 20-30x seems to be fair and not expensive in recent tech super cycle. 

However, will the PE valuation ever go back to 40-60x again when the sentiment in stock market improves later?

I really don't know. Who knows the PE might go back to 15-20x region when the worry of semiconductor oversupply emerges?

Anyway, tech related companies with high growth potential should be a safer bet.

Thursday, 3 March 2022

My Portfolio Feb22

 












Summary For February 2022











Portfolio @ End of Feb22












In Feb22, KLCI registered a superb monthly gain of 6.35%, mainly due to the gain of blue chips plantation and banking stocks.

Technology related stocks continue to suffer as there seems to be a second round of sell-off. 

My portfolio has quite a number of tech-related stocks but it has been "saved" by Hibiscus again. Overall it's a flat month to me.

The hottest headlines recently is undoubtedly the invasion of Ukraine by Russia. It has resulted in the spike in certain commodities price such as crude oil, crude palm oil, soybean and aluminum etc.

When the US warned the world of the potential invasion of Ukraine by Russia earlier in February, I think not many people believed that it will ever happen.

We are living in a modern "civilized" world now. Even though there are still lots military conflicts around the globe, an "unprovoked" invasion of a sovereign country by a super power is almost unheard of.

Perhaps Ukraine or certain country has done something that provoked Russia but such brutal action of destruction to properties and life is definitely not right.

Wednesday, 9 February 2022

My Portfolio Jan22



Summary for January 2022











Portfolio @ End of Jan22













The first month of year 2022 was not a good month to the stock market as KLCI dropped 3.5%.

Tech-related stocks led the drop with approximately 20% slash in their share prices.

My portfolio could not escape from the bad sentiment and registered 1.2% loss in the month of January 2022.

The share price of the hopeless Fast Energy fell the most at 26% but it did not affect the overall portfolio much as the value is already very small.

JHM & Gtronic were the worst performers apart from Fast but overall loss was minimized by the 23.9% rise in Hibiscus's share price.

I sold part of my Hibiscus shares earlier at 88sen which was at the wrong timing again.

Besides Hibiscus, I sold all my LeonFB shares at 87.5sen, also shortly before its share price advanced to RM1 level.

I realized a bit of profit from myNews just to hold a bit more cash. All these selling acts were in anticipation of upcoming Omicron wave after Chinese New Year.